University of Birmingham
The role of CD8+ regulatory T cells in anti-tumour immune responses in Hepatocellular Carcinoma
Abstract
dc:description.abstractTumour specific effector T-cells can be detected in the blood and tumours of patients with hepatocellular carcinoma (HCC) but fail to mount effective immune responses. Attempts to amplify anti-tumour immune responses using immunotherapy show promise, but are hampered by the presence of suppressive regulatory T-cells (Treg) that inhibit anti-tumour immune responses. Many different subsets of Treg have since been identified including regulatory T-cells expressing the surface marker CD8 (CD8+Treg). A set of experiments was designed in an attempt to increase our understanding on how CD8+Treg may disrupt anti-tumour response and by what mechanisms they are induced. CD8+Treg was analysed by isolation of liver-derived T-cells from human HCC. Monocyte-derived dendritic cells (moDC) matured with tumour tissue conditioned medium were used to assess they potential to induce CD8+Treg. CD8+Treg infiltrating HCC demonstrated a suppressive phenotype. The co-culture of naïve CD8+T-cells with tumour-conditioned moDC induces a population of CD8+Treg through an IDO dependent mechanism. This population of induced T-cells was able to suppress via the CD39-adenosine pathway. The findings of the mechanisms involved in the induction of CD8+Treg by DC and the involvement of CD39 in the suppressive capacity of these novel T-cells, may guide the development of future immunotherapeutic in HCC.
Degree
thesis:*- Name dc:type.qualificationname
- d_ph
- Level dc:type.qualificationlevel
- d_ph
- Grantor dc:publisher.institution
- University of Birmingham
- Year dc:date.issued
- 2018
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Li, Ka-Kit
Subjects
dc:subject × 2Rights
- Language dc:language.dcterms_iso639_2
- eng